Cargando…
Characterization of a Novel SOD-1(G93A) Transgenic Mouse Line with Very Decelerated Disease Development
Amyotrophic Lateral Sclerosis (ALS) is a fatal motoneuron disease, characterized by progressive weakness, muscle wasting and death ensuing 3–5 years after diagnosis. The etiology of ALS is complex and therapeutic approaches rely mostly on transgenic animal models with SOD-1 mutations. Most frequentl...
Autores principales: | Henriques, Alexandre, Pitzer, Claudia, Schneider, Armin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978730/ https://www.ncbi.nlm.nih.gov/pubmed/21102999 http://dx.doi.org/10.1371/journal.pone.0015445 |
Ejemplares similares
-
Gene expression changes in spinal motoneurons of the SOD1(G93A) transgenic model for ALS after treatment with G-CSF
por: Henriques, Alexandre, et al.
Publicado: (2015) -
Characterization of somatosensory neuron involvement in the SOD1(G93A) mouse model
por: Rubio, Miguel A., et al.
Publicado: (2022) -
Genetic Biomarkers for ALS Disease in Transgenic SOD1(G93A) Mice
por: Calvo, Ana C., et al.
Publicado: (2012) -
Analytical sequence to study G-CSF effect on the transcriptome of isolated spinal motoneurons from SOD1 G93A mice, an animal model for amyotrophic lateral sclerosis
por: Henriques, Alexandre, et al.
Publicado: (2015) -
Dysregulation of the complement cascade in the hSOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis
por: Lee, John D, et al.
Publicado: (2013)